Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

NICE fate to be determined by interferon-Β/MS debate?

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    NICE fate to be determined by interferon-Β/MS debate?. Pharmacoecon. Outcomes News 271, 4 (2000). https://doi.org/10.1007/BF03275525

    Download citation

    Keywords

    • Multiple Sclerosis
    • Outcome News
    • National Health Service
    • Clinical Excellence
    • Advocate Group